Molecular Subtyping of Triple‐Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance

BACKGROUND: Molecular subtyping of triple‐negative breast cancers (TNBCs) via gene expression profiling is essential for understanding the molecular essence of this heterogeneous disease and for guiding individualized treatment. We aim to devise a clinically practical method based on immunohistochem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Zhao, Shen, Ma, Ding, Xiao, Yi, Li, Xiao‐Mei, Ma, Jian‐Li, Zhang, Han, Xu, Xiao‐Li, Lv, Hong, Jiang, Wen‐Hua, Yang, Wen‐Tao, Jiang, Yi‐Zhou, Zhang, Qing‐Yuan, Shao, Zhi‐Ming
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Breast Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543239/
https://ncbi.nlm.nih.gov/pubmed/32406563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0982
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars